Aduhelm's accelerated approval for the treatment of Alzheimer's Disease
Madam, despite the life-threatening manifestations that Alzheimer's disease (AD) possesses, to date, only five medical treatments have been approved for AD, which involve two classes of drugs that merely control the symptoms rather than altering the course of the disease. Moreover, in the last...
Main Authors: | Aayat Ellahi Buksh, Fahd Shaikh, Hasnain Mankani |
---|---|
Format: | Article |
Language: | English |
Published: |
Pakistan Medical Association
2022-04-01
|
Series: | Journal of the Pakistan Medical Association |
Online Access: | https://www.ojs.jpma.org.pk/index.php/public_html/article/view/4368 |
Similar Items
-
Myocarditis following administration of COVID-19 Vaccine – Should we be worried?
by: Aayat Ellahi Buksh, et al.
Published: (2022-08-01) -
The effect of vitamin D deficiency on Inflammatory disorders
by: Naz Elahi, et al.
Published: (2023-04-01) -
An update on the novel and approved drugs for Alzheimer disease
by: Hassan Ahmad Alhazmi, et al.
Published: (2022-12-01) -
The accelerated approval process in oncology : an examination of the conversion rate of approved therapies to full approval
by: Kim, Jean Jinsun
Published: (2007) -
Accelerated Aging Characterizes the Early Stage of Alzheimer’s Disease
by: Alessandro Leparulo, et al.
Published: (2022-01-01)